On 9/1, Duke-Margolis and the FDA's Quantitative Medicine Center of Excellence are co-convening a virtual event to inform the establishment of the Quantitative Medicine Innovation Network. A draft agenda is now available! Learn more about the topics of discussion and register here: duke.is/8/4p56

On September 29, Duke-Margolis and the FDA Rare Disease Innovation Hub are co-convening a new hybrid workshop to explore statistical considerations in the design, conduct, and analysis of clinical investigations for rare disease medical products: duke.is/2/z3fw

A draft agenda is available for the upcoming virtual workshop, "Statistical Considerations for Digitally-Derived Endpoints in Clinical Trials," which we are convening under a cooperative agreement with the U.S. Food and Drug Administration. Learn more and register here: duke.is/4/7rtf

Join us on 7/27 for our annual State of RWE Policy convening, where experts will consider how RWD/E can routinely inform regulatory and coverage decisions, integrate research into patient care, and foster greater harmonization across the health policy ecosystem: duke.is/2/ynaf

Drop by the Duke Summer Research Showcase on Friday, July 24, from 10:00 am - 12:00 pm at Bostock Library, The Edge, to support over 130 student researchers—including our wonderful Summer Experience interns—who are presenting posters about their Duke-sponsored summer research. #DukeExperiences

Join us next week for our hybrid workshop as we examine opportunities to improve how biomarker evidence supports regulatory decision-making in individual product submissions. Learn more about our speakers & topics of discussion, read our preliminary policy roadmap, and register here: duke.is/2/7sb2

Duke-Margolis has created a new framework of Real-World Evidence (RWE) Policy Core Competencies, a skillset that will prepare tomorrow’s RWE policy leaders to solve today’s—and tomorrow’s—toughest RWE policy challenges with evidence, innovation, and impact. Read more here: duke.is/4/scwe

Influenza is a persistent public health challenge with significant morbidity, mortality, and economic costs. Duke-Margolis has released a new policy brief that outlines short- and long-term policy priorities to modernize seasonal influenza vaccine development: duke.is/2/4va5

Don't miss your chance to register! Our next event is coming up on Tuesday, June 23, where we will explore opportunities to modernize seasonal influenza vaccine development. Register today: duke.is/m/smgn

Join us on July 15 for a hybrid workshop designed to inform a policy roadmap to improve the use of biomarkers and surrogate endpoints in regulatory decision-making for individual product submissions. Learn more and register here: duke.is/2/7sb2

Missed out on the 2026 Health Policy Conference or want to review the discussion that took place? An event summary is now available to read and share! The summary provides quick highlights from each session and features some quotes from our speakers: duke.is/HPC2026Summary

We would like to sincerely thank the Peterson Center on Healthcare for their support of our 2026 Health Policy Conference. The Center was established by the Peter G. Peterson Foundation to make higher-quality, more affordable health care a reality for all Americans: petersonhealthcare.org

Our 2026 Health Policy Conference featured a group of wonderful speakers and timely health policy topics, but the conversation was only possible through the support of our sponsors. We offer our most sincere thanks to Johnson & Johnson for sponsoring this year’s conference: www.jnj.com

We extend our most sincere thanks to Alexandria Ventures for sponsoring our 2026 Health Policy Conference. Their support will allow us to continue gathering annually and host these crucial health policy conversations. Learn more about Alexandria here: www.are.com

A draft agenda is now available for our upcoming meeting! Join us on May 19 as we explore solutions to chronic drug shortages, national health security risks associated with foreign dependence, and challenges related to quality assurance: duke.is/v/4g5n

WEDNESDAY: Join Duke-Margolis and the U.S. Food and Drug Administration (FDA) for a public webinar to provide updates on RCT-DUPLICATE, one of the FDA’s demonstration projects addressing key methodological challenges in studies using real-world data. Register today: duke.is/4/5a35

This Thursday: Join Duke-Margolis and the U.S. Food and Drug Administration for a conversation on "Increasing Access to Nonprescription Drugs"! Register today: duke.is/p/4g3b

How can we transform health and improve health outcomes in the rural United States? Speakers will explore this issue during a session at the Duke-Margolis 2026 Health Policy Conference on May 13. Join us for this conversation and a wide range of other timely health policy topics! duke.is/HPC2026

Join us for a special Duke-Margolis Seminar featuring Anup Malani, Chief Economist at CMS! Enrollment in ACA individual market plans with zero claims raises important questions about enrollee health status, coverage transitions to Medicaid, and the potential for improper enrollment: duke.is/m/9e8n

Our next event is just a few days away! Don't miss your chance to register for "Scaling Innovative Clinical Trial Approaches: Challenges, Progress, and Opportunities," where speakers will explore strategies to encourage broader adoption of innovative clinical trial approaches: duke.is/m/qy4t

As clinical tools are embedded in clinical care, new opportunities to improve patient care increase but so do new patient safety risks.

Registration closes soon! Join us on Monday for the third workshop in the RISE series, co-convened with the FDA Rare Disease Innovation Hub, where our expert speakers will explore the potential of data sharing to advance rare disease clinical trials and medical product development: duke.is/2/t6dr

In just a few weeks, we are co-hosting an event with the Duke Health AI Evaluation & Governance Program! As clinical AI tools are increasingly embedded in care delivery, proactive risk management is needed. Join us on 3/24 and explore strategies to protect patients in the age of AI: duke.is/5/cg7u

Join us this Friday for our next public webinar! We look forward to discussing the CIC's new Health Value Evidence Quality Framework, which outlines stages of evidence quality analysis across the investment life cycle and highlights real-world case examples. Register here: duke.is/w/65xf

The new Health Value Evidence Quality (HV-EQ) Framework from our Capital Impact Council (CIC) outlines guidance to help assure private investments in health care deliver health value alongside financial returns: duke.is/HVEQ

Duke-Margolis has released a new white paper! The authors discuss best practices for curation of real-world data sourced from electronic health records, aiming to preserve clinical meaning and analytical reliability. Read more here: duke.is/b/n2dv

Our next public event starts in an hour! One of the collaborative efforts that will be highlighted in today's webinar is the West Health & Duke-Margolis Accelerator's Accountable Care Learning Hub, which provides many useful resources for accountable care transformation:

Our next event is just a few days away! There's still time to register for the rapid learning webinar we are hosting with support from West Health. Speakers will explore how collaborative action can advance rapid learning and, in turn, address accountable care policy challenges: duke.is/6/ef23

There’s still time to register! The 10th Anniversary of the HCPLAN: Celebrating a Decade of Advancing Value-Based Care virtual event takes place on 2/2 from 2-4pm ET. Hear from Mark McClellan as speakers reflect on a decade of progress and look toward the future. Register today: bit.ly/4qzHuP0

Welcome back, Duke students! Don't forget that our Undergraduate Scholar applications are open until 1/12. Our Margolis Scholars program is a great supplement to your degree program that can provide you with the competencies needed for a career in health policy: healthpolicy.duke.edu/scholars